Join us at the 2025 ASCO® Annual Meeting

At NeoGenomics, we are always innovating to improve the cancer care continuum for your patients and this year we're proud to showcase the latest.

Visit booth #11093 to explore:

  • Our new PanTracer portfolio for all your solid tumor comprehensive genomic profiling needs. PanTracer LBx, PanTracer Tissue and PanTracer Tissue + HRD (coming soon).
  • Paletrra™ is our latest product for BioPharma partners who want visual insights from spatial analysis. Come explore the latest in clinical advancement support.

Schedule a meeting!

Get to know

NEO|PanTracer™ Tissue & NEO|PanTracer™ LBx

Explore the latest in next-generation diagnostic solutions for patients with advanced-stage solid tumors. The PanTracer portfolio empowers oncologists with actionable genomic insights for confident, real-time treatment decisions. Whether you're selecting targeted therapies or exploring clinical trials, working from a liquid or tisssue biopsy, PanTracer ensures that you're equiped with the insights you need.

Paletrra™

Paletrra is a spatial proteomics solution that transforms tissue into deep visual insights that fuel confident decisions and accelerate informed clinical advancement. Paletrra revolutionizes spatial biology, translating precious tissue into therapeutic advancements.

Hey, Neo!

During the 2025 ASCO® Annual Meeting, stop by booth #11093 to try our voice-enabled AI activity, Hey Neo. Interact with a personal oncology virtual assistant and discover how our tests, including PanTracer LBx, PanTracer Tissue, and PanTracer Tissue+HRD (coming soon!), can support your patient care.

Product highlights

© NeoGenomics Laboratories
9490 NeoGenomics Way
Fort Myers, FL 33912
Privacy Policy